caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518928514

Anna BelchevaM. D.

Medical OncologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Anna Belcheva's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 20 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
72491
David Katz
Diagnostic Radiology · Houston, TX
19121
Andre Lighvani
Diagnostic Radiology · Philadelphia, PA
1854
Lucho Rossman
Diagnostic Radiology · Houston, TX
18116
NORTH CYPRESS MEDICAL CENTER OPERATING COMPANY, LTD.1749
Sanjay Kunapuli
Interventional Cardiology · Houston, TX
17285
SUTTON, PHILLIP1638
KHAMAPIRAD, TUENCHIT1634
Nam Yu
Diagnostic Radiology · Los Angeles, CA
1576
John Labis
Diagnostic Radiology · Houston, TX
1458
Rajeshwar Abrol
Gastroenterology · Tomball, TX
14103
NEW MEDICAL HORIZONS II, LTD.1337
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
189
By payment type
Food and Beverage$4K
Education$144
Top paying entities
Food and Beverage$4K
Education$144
PRESCRIBING · PART D · 2024
Total Rx claims
731
Beneficiaries
—
Total drug cost
$592K
Distinct drugs
28
Brand share
28.3%
Top prescribed drugs
Anastrozole129 claims
Hydrocodone/Acetaminophen60 claims
Tamoxifen Citrate56 claims
Tramadol Hcl35 claims
Prednisone34 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,322
Unique beneficiaries
—
Total services
63,006
Distinct HCPCS
28
Medicare payment
$787K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 393 Medical Oncology providers in TX — top quintile (cohort median 4,999).